A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD
ACR 22 Convergence Preview, with Dr. McMahan
Rare Disease Report: The FDA Decision for Pompe Disease Therapy
Arshad Khanani, MD: A Breakthrough in Geographic Atrophy Treatment
Rare Disease Report: Newborn Screening Awareness & Novel Diagnostic Tool
Heart Team: Making Ground on Women's Cardiovascular Health with Martha Gulati, MD
Marla Dubinsky, MD: The Future of IIL-23 Treatments for IBD
Heart Team: Cardiology & Nephrology Collaborations with Dr. Matthew Weir
Rare Disease Report: CDKL5 Deficiency Disorder Expert Interview
Rare Disease Report: CDKL5 Deficiency Disorder
John J. Miller, MD: A New Era For Psychiatric Medications
Nonprofit Research on Gene Therapy for Rare Ocular Diseases
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030
The Biggest Discussions in Retina from the 2022 ASRS Annual Meeting
FDA Approves Ruxolitinib: New Horizons in Vitiligo Care
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
What Ustekinumab Provides in Long-Term IBD Care
Exploring New Horizons in Ophthalmology Care with Gene Therapy
How the Newest Dupilumab Approval Solves an "Unmet Need" in Children with AD
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
Sleeping Through Infectious Disease and the COVID-19 Vaccine
Multi-System Approaches to Treating Pediatric Morphea
Roberto Simons-Linares, MD: The Importance of Bariatric Surgery
Rare Disease Report: Myelodysplastic Syndromes & Acute Myeloid Leukemia
How Tapinarof Cream 1% is Set to Revolutionize Psoriasis Care
Improving Screening Strategies for Cardiac Sarcoidosis
What's Limiting Medical Marijuana Therapy in Rheumatology?
Improving the Availability of COVID-19 Therapeutics in Vulnerable Communities
A Medical Volunteer at the Ukraine-Poland Refugee Border
New Methods for Overcoming Environmental and Food Allergies
Evaluating the Efficacy of Faricimab in Patients with DME from Underrepresented Communities
Rare Disease Report: TANGO2
How Determi-Nation Promotes Diversity in Psoriatic Research and Treatment
NAFLD Prevalence Increasing in Pediatric Patients
Approximately 9 Million More Americans Exposed to Air Pollution in 2022
How JAK Inhibitors Revolutionized Dermatology Care
Exploring New Possibilities in Vitiligo Therapy
Addressing Rising Insomnia Rates in the United States
Overdrive Podcast: ArthritisPower Redesign and Research
Introducing Insulin Therapy and Dietary Care to Patients with Diabetes
Diagnosing and Treating Rosacea : An Overview
Ardythe Morrow, PhD: The Connection Between Gut Bacteria and Psychiatric Disorders
Why Dermatologists Diagnose Psoriasis Less in Black Patients
Rare Disease Report: Relapsing Polychondritis
Improving Racial and Ethnic Representation in Pediatric Trials
How Dermatologists Combat Misinformation on Social Media
The Promise of FT218 Therapy for Narcolepsy Patients
Overdrive Update: Guselkumab for Treating Active Psoriatic Arthritis Part 2
Revising the CDC Clinical Guideline for Prescribing Opioids
next page